Continuing Education  » Oncology  » Pet Cancer Summit - Session 4: Osteosarcoma and Hemangiosarcoma

Pet Cancer Summit - Session 4: Osteosarcoma and Hemangiosarcoma

CE Event Information

  • Description:
    Osteosarcoma and hemangiosarcoma are two fairly common types of cancer to affect dogs. Historically, both tumor types have been associated with poor long-term prognoses, however those beliefs are based on older information. Recent advances in cancer diagnostics and treatment are transforming the options we have for caring for dogs affected with these two diseases and outcomes.

    We will begin this session discussing osteosarcoma – a malignant and aggressive cancer of bone. In years past, therapy was considered limited to limb amputation followed by chemotherapy however our approach to these patients has evolved to include other considerations.

    Dr. Karri Meleo, a board certified medical and radiation oncologist, will begin the discussion talking about non-invasive radiation therapy and stereotactic radiation therapy for dogs with bone tumors, and how it is employed for palliation or with a curative intent.

    Dr. Joanne Tuohy, a board certified veterinary surgeon and Fellow in Surgical Oncology, will then fold in a surgeon’s perspective on this disease and will discuss the role of a veterinary limb salvage, novel tumor ablation approaches for primary and metastatic osteosarcoma, and some combination therapeutic approaches to improve patient outcomes.

    The second half of this session will concentrate on hemangiosarcoma in dogs. We will hear from two researchers at the University of Minnesota about our current understanding of hemangiosarcoma and what we can do about it ... now!

    Drs. Erin Dickerson and Antonella Borgatti will create an understanding of the distinct subtypes of hemangiosarcoma and how these impact survival and responses to treatment. They will also update us on current accepted treatment approaches and debunk myths about all of the others. Lastly, they will inform us about clinical trials and how the results are paving the way to new and improved therapies for canine hemangiosarcoma.


    Registration is FREE for VetVine Premium Membership subscribers.
  • Date: November 13, 2024
  • Time: 7:30 PM US/Eastern
  • Sponsor: VetVine, Virginia Tech Animal Cancer Care and Research Center, PetCure Oncology
  • Presenter(s): Karelle Meleo, DVM, DACVIM (Oncology), DACVR (RO), Joanne Tuohy, DVM, PhD, DACVS (Small Animal), ACVS Fellow in Surgical Oncology;, Erin Dickerson, PhD; Antonella Borgatti, DVM, MS, DACVIM (Oncology), DECVIM-CA;
  • Fee (Basic Membership): $36